Stay updated on Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents a significant recruitment challenge encountered by the POLEM study, leading to recruitment being halted at 30 patients enrolled from the original target of 402.
    Difference
    0.1%
    Check dated 2024-06-06T14:36:21.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria'. This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    31%
    Check dated 2024-05-22T21:36:53.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:19:15.000Z thumbnail image

Stay in the know with updates to Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.